News

Results found (485)
April 5, 2007
Yissum spin-off Novagali succeeds in Phase III clinical trials

Novagali Pharma Announces Positive Vekacia(R) Clinical Results from Pivotal Phase III Trial in Vernal Keratoconjunctivitis

 

April 4, 2007
The featherless broiler is ready to go to market

Four years after the first information on featherless broiler research was known, the attention of the public and world media was attracted. Commercial trials show the big advantage over their feathered relatives, especially when kept in tropical...

March 25, 2007
Yissum licenses a new anti-inflammatory technology to Bioline (Hebrew article)

Bioline will develop a new drug based on the technology of Prof. Hillel Bercovier and Dr. Ayelet Barenholz of the Hebrew university. 

 

February 28, 2007
Target-In to collaborate with US biotech co KaloBios

The agreement is reportedly worth several million dollars. 

 

January 30, 2007
New agreement signed between Target-In and Century Pharmaceuticals (Hebrew...

Yissum subsidiary Target-In and Indian company Century Pharmaceuticals will jointly develop a new drug for asthma and allergy, which will be based on the molecule developed by the Israel company.  

(Hebrew article attached)

January 30, 2007
Yissum & Hebrew University to open first multi-diciplinary center

A facility for cross-disciplinary scientific research on a more comprehensive scale than has been

attempted anywhere is being launched by the Hebrew University of Jerusalem, in cooperation

with Yissum, the technology transfer company of the...

January 20, 2007
Israeli tomatoes big hit in Europe

These yellow cherry tomato seeds, named Summer Sun, were developed by Hazera

Genetics, part of the French-based global group Vilmorin Clause & Cie, in

collaboration with the Faculty of Agriculture at the Hebrew University.

December 25, 2006
Yissum subsidiary SCT wins 2M NIS grant for juvenile diabetes research...

This grant was received from the World Fund for Juvenile Diabetes Research and D-Cure. (Hebrew article attached)

October 31, 2006
Kazakhstan Minister of Science & Education visits Yissum (Hebrew article)

Yissum will aid Kazakhstan in establishing technology transfer facilities as part of the Kazakhstan National Center for Biotechnology.  (Hebrew article attached)

August 8, 2006
BioCancell IPO oversubscribed by 3.45%

Biocancell Therapeutics Ltd.’s IPO benefited from both investor confidence in the company and lucky timing. Scheduled during the war, it was held on the day the cease-fire went into effect, when trading on the Tel Aviv Stock Exchange (TASE) was...

December 16, 2005
Israeli Company Masters The Art Of Tech Transfer

An Israeli university that numbers physicist Albert Einstein among its founders has become a

crucible on transforming research into successful products.

December 1, 2005
Science Means Business- Yissum and the Hebrew University

It is one of the largest patent filers in

the world, holds a bigger portfolio

than most venture funds, is parent to 60

spin-off companies and originates a billion

dollars in product sales each year...